CLINICAL_TRIALS
trial_result
· 2014-08-28
Clinical Trial Update: Phenylketonuria, Oxidative Stress, and BH4 [Phase 2]
Summary
A Phase 2 trial evaluating tetrahydrobiopterin (BH4) in phenylketonuria was terminated, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Phenylketonuria | Phase 2 | Status: TERMINATED | Results posted: 2014-08-28